Health ❯ Research ❯ Clinical Trials

Drug Development

Breakthrough Treatments Neuroprotective Agents Mitochondrial Medicine G Protein-Coupled Receptors Future Treatments Gene Therapy GLP-1 Receptor Agonists Lithium Compounds Future Prospects Innovative Therapies ACLY Inhibition Gerontology Nitisinone Trials Kinase Inhibitors Targeted Therapy Experimental Medications Alzheimer's Drug RI-AG03 Safety and Efficacy Cancer Therapies

5 ARTICLES

last mo.

Copper Compound Restores Brain Clearance Pump and Cuts Alzheimer’s Proteins in Mice

Researchers say prior human safety testing for the drug in Parkinson’s and ALS supports moving toward trials even though how the brain clears the proteins remains unclear.

4 ARTICLES

2mo ago

Lithium Chloride Rewires Alzheimer’s-Linked Pathways in Cell Study

6 ARTICLES

6mo ago

UCL Analysis Finds APOE Variants Drive Most Alzheimer’s Cases

3 ARTICLES

10mo ago

Tufts Team Designs Experimental Four-Hormone Obesity Drug Aimed at Bigger, Gentler Weight Loss

3 ARTICLES

this yr.

ACLY Inhibitor Triggers B Cell Response to Suppress Liver Tumors and Advances Toward Clinical Trials

3 ARTICLES

last yr.

UCSF Validates GPCR ADGRG1’s Role in Clearing Alzheimer’s Plaques, Paving Way for New Therapies

4 ARTICLES

last yr.

MLi-2 Kinase Inhibitor Fully Restores Neuronal Cilia and Promotes Recovery in a Parkinson’s Mouse Model

9 ARTICLES

last yr.

Cancer drug pair extends mouse lifespan by 30% as researchers plan human trials